About Phosphorex
Phosphorex is a Technology company based in Hopkinton (United States) founded in 2005 by Bin Wu. Polymeric nanospheres, microspheres, and drug delivery solutions are developed. It operates in the Technology and Healthcare sectors. Phosphorex offers products and services including Lipid Nanoparticles, Polymeric Nanoparticles, and Polymeric Microspheres. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is PHOSPHOREX, INC. Its competitors include Sirnaomics, Arcturus Therapeutics and Ensysce; 3 of its 3 listed competitors have raised funding.
Company details
Phosphorex was established in 2005 in Hopkinton, United States, within the biotechnology sector. Polymeric nanospheres and microspheres are produced for drug delivery applications. Products such as polystyrene nanobeads and latex beads, available in plain, color-dyed, fluorescent, or luminescent forms, are manufactured. Services encompass drug molecule encapsulation into nanoparticles, development of self-emulsifying systems, and nanosizing of insoluble particles to sub-micron sizes, thereby enhancing solubility and bioavailability.
- Headquarters Hopkinton, United States
- Founders Bin Wu
- SectorsTechnologyHealthcare
- Email••••••••
- Website phosphorex.com
- Social LinkedIn X Facebook YouTube
- Legal Name Phosphorex, Inc.
- InvestorsNof corporation
& 1 more
Products & Services of Phosphorex
Phosphorex offers a comprehensive portfolio of products and services, including Lipid Nanoparticles, Polymeric Nanoparticles, and Polymeric Microspheres.
Facilitates cellular entry and endosome escape for nucleic acid therapies.
Enables surface-modified nanoparticles for targeted drug delivery.
Optimizes drug release profiles for long-acting therapeutic effects.
Apps and channels of Phosphorex
its YouTube channel Phosphorex has 28 subscribers and 13 videos.
Videos from Phosphorex
The most watched videos on Phosphorex's YouTube channel, Phosphorex (28 subscribers). Click a video to play it here.
More on Phosphorex .
Funding Insights of Phosphorex
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Phosphorex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | Series A | – | – | ||
| Aug 2022 | Private Equity Round | – | Ampersand Capital | – |
2 investors in total: 2 institutional.
Investors in Phosphorex
Phosphorex has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Nof corporation and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | ampersandcapital.com | Boston, United States | ||
Oleo and specialty chemicals are supplied by Nof Corporation. | 1949 | nof.co.jp | Shibuya, Japan |
Investor details for Phosphorex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Phosphorex
15 people are tracked at Phosphorex (10 in leadership, 2 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Bin Wu | Founder | Leadership |
Nicholas Boylan | Director, Nucleic Acid Delivery | Leadership |
Theresa Logan | Senior Director, Lab Operations & MSAT | Leadership |
Matthew Wingate | Director, Manufacturing, Science & Technology, MSAT | Leadership |
Evan Turek | Business Development Director | Leadership |
Jarlath Keating | CEO | Leadership |
Mario Reto | Vice President | Leadership |
David Tammaro | CFO | Leadership |
Kim Yang | Director, Marketing | Leadership |
Marc Kinnelly | VP, Quality Operations | Leadership |
Paul H. Johnson | Board Member | Board & advisors |
Trevor L. Wahlbrink | Board Member | Board & advisors |
Phosporex Inc. | Drug Delivery Services | Team |
Julia Tauscher | Researcher And Technical Support Specialist | Team |
Qian Xu | Associate Research Scientist | Team |
Complete people profiles for Phosphorex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Phosphorex
3 dated milestones of Phosphorex across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Phosphorex is founded.
- Funding First funding round.
- Funding Latest funding round, Series A,.
Competitors of Phosphorex
Phosphorex has 3 listed competitors in our database, 3 of them funded. They include Sirnaomics, Arcturus Therapeutics and Ensysce.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sirnaomics.com | 2007 | Gaithersburg, United States | $267M | 88 | RNA-based therapeutics for cancer and fibrosis are developed. | |
| arcturusrx.com | 2013 | San Diego, United States | $1.3M | 337 | RNAi technologies are developed for treating rare orphan diseases. | |
| ensysce.com | 2008 | Houston, United States | $2.5M | Drug delivery solutions via single-walled carbon nanotubes are offered. |
Detailed competitors of Phosphorex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Phosphorex
The website of Phosphorex (phosphorex.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▼ 30.4% vs previous month
Websites whose visitors overlap most with Phosphorex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| us-nano.com | 100% | #1,965,411 | View details | ||
hielscher.com | hielscher.com | 95% | #389,226 | – | |
| rsc.org | 95% | 5M | #14,264 | View details | |
| cytodiagnostics.com | 76% | #4,012,041 | View details | ||
antwifarms.com | antwifarms.com | 59% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Phosphorex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nanotechnology
3 companies that operate in the same segment as Phosphorex (Nanotechnology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Phosphorex
Complete news archive for Phosphorex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phosphorex
Phosphorex was founded in 2005 and raised its 1st funding round 17 years after it was founded.
Phosphorex is headquartered in Hopkinton, United States. It is registered at Hopkinton, Massachusetts, United States.
Phosphorex was established in 2005 in Hopkinton, United States, within the biotechnology sector. Polymeric nanospheres and microspheres are produced for drug delivery applications. Products such as polystyrene nanobeads and latex beads, available in plain, color-dyed, fluorescent, or luminescent forms, are manufactured. Services encompass drug molecule encapsulation into nanoparticles, development of self-emulsifying systems, and nanosizing of insoluble particles to sub-micron sizes, thereby enhancing solubility and bioavailability.
Phosphorex's top competitors include Sirnaomics, Arcturus Therapeutics and Ensysce.
Phosphorex offers Lipid Nanoparticles, Polymeric Nanoparticles, and Polymeric Microspheres.
Phosphorex has 2 investors. Key investors include Nof corporation, and Ampersand Capital Partners.
Phosphorex operates through Phosphorex, Inc..